Value Through Innovation28 August 2014

Annual Advancement in PRRS Research Award

At Boehringer Ingelheim Vetmedica, Inc., we're furthering our commitment to research efforts for PRRS control.

Each year we issue a call for proposals for the Annual Boehringer Ingelheim Advancement in PRRS Research Award Program. The deadline for submissions are January 1 of each year.

Boehringer Ingelheim will provide three U.S. $25,000 awards to the winning proposals for PRRS research in the NAFTA region. Candidates included graduate students, academic researchers, company or private researchers, and practicing veterinarians.

The 2014 Advancement in PRRS Research Awards recipients will be announced at the American Association of Swine Veterinarians Conference on March 3, 2014.

Objective: Examine practical methods of controlling, managing, and possibly eradicating the PRRS virus.

Once the three winning year-long research projects are completed and submitted for peer review, PRRS Research Review Board (PRRB) will conduct a second evaluation. Upon acceptance for publication of his or her findings, the first place award recipient will receive an additional U.S. $5,000; second place, $3,000; and third place, $1,000.

The independent PRRS Research Review Board (PRRB) members include:

  • Luc Dufresne, DVM, Seaboard Farms, Shawnee Mission, Kansas
  • Tim Loula, DVM, Swine Vet Center, P.A., St. Peter, Minnesota
  • Bill Mengeling, DVM, PhD, Diplo. ACVM, Iowa State University, Ames, Iowa (Retired)
  • Daryl Olsen, DVM, AMVC, Audubon, Iowa
  • Montse Torremorell, DVM, PhD, University of Minnesota, Minneapolis, Minnesota
  • AASV President Elect
    Ron Broderson, DVM, Whole Hog Health Center, Hartington, Nebraska
Our independent PRRS Research Review Board members look forward to reviewing your proposal.

Proposals Due

The deadline for proposals for the 2015 Boehringer Ingelheim Vetmedica PRRS Research Award is: January 1, 2015

Submit Your Proposal To:

  • The Advancement in PRRS Research Award

    Boehringer Ingelheim Vetmedica, Inc.
    Attn: Trudy Luther
    3902 Gene Field Rd
    St. Joseph, Missouri 64506


About Boehringer Ingelheim Vetmedica

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavors.

In 2012, Boehringer Ingelheim achieved net sales of about 14.7 billion euro. R&D expenditure in the business area Prescription Medicines corresponds to 22.5% of its net sales.

For more information please visit www.boehringer-ingelheim.com

Contact Us

  • The Advancement in PRRS Research Award

    Boehringer Ingelheim Vetmedica, Inc.
    Attn: Trudy Luther
    3902 Gene Field Rd
    St. Joseph, Missouri 64506